Citadel Advisors’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-51,693
| Closed | -$29K | – | 6768 |
|
2023
Q2 | $29K | Buy |
51,693
+10,154
| +24% | +$5.69K | ﹤0.01% | 5159 |
|
2023
Q1 | $47.4K | Sell |
41,539
-5,604
| -12% | -$6.39K | ﹤0.01% | 5179 |
|
2022
Q4 | $52.8K | Buy |
47,143
+25,582
| +119% | +$28.7K | ﹤0.01% | 5259 |
|
2022
Q3 | $46K | Buy |
+21,561
| New | +$46K | ﹤0.01% | 5347 |
|
2022
Q2 | – | Hold |
0
| – | – | – | 7227 |
|
2022
Q1 | – | Hold |
0
| – | – | – | 7403 |
|
2020
Q3 | – | Sell |
-14,880
| Closed | -$100K | – | 5446 |
|
2020
Q2 | $100K | Sell |
14,880
-44,943
| -75% | -$302K | ﹤0.01% | 4239 |
|
2020
Q1 | $190K | Buy |
+59,823
| New | +$190K | ﹤0.01% | 4102 |
|
2019
Q4 | – | Sell |
-46,594
| Closed | -$179K | – | 5263 |
|
2019
Q3 | $179K | Buy |
46,594
+14,898
| +47% | +$57.2K | ﹤0.01% | 4152 |
|
2019
Q2 | $120K | Buy |
+31,696
| New | +$120K | ﹤0.01% | 4247 |
|